Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Clinical trial NCT03948035 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03948035
- Sponsor
- Wuerzburg University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2029-08-01
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.